Suppr超能文献

持续性生活质量差与炎症性肠病患者未来阿片类药物使用的关联。

The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.

机构信息

University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

出版信息

Inflamm Bowel Dis. 2018 Jun 8;24(7):1380-1388. doi: 10.1093/ibd/izy040.

Abstract

BACKGROUND

Inflammatory bowel disease (IBD) is associated with poor quality of life and disability. The short inflammatory bowel disease questionnaire (SIBDQ) is validated to determine patients quality of life at single time points, or improvement over time. Few studies have evaluated if sustained poor quality of life is associated with future healthcare utilization patterns.

METHODS

We analyzed patients from a prospective IBD natural history registry with 4 consecutive years of follow-up. SIBDQ was measured at outpatient visits. Healthcare utilization data were temporally organized into a 2-year observation period, and 2-year follow-up period. Mean SIBDQ score <50 during the first 2 years was categorized as having "poor quality of life". Primary outcomes of interest were measures of unplanned healthcare utilization and opioid use.

RESULTS

From a total of 447 participants (56.1% female, 66.1% Crohn's disease, 34.9% ulcerative colitis), 215 (48.1%) were classified as having poor quality of life. Poor quality of life was significantly associated with Crohn's disease (P < 0.01), history of IBD related surgery, and tobacco use (all P < 0.01). In the follow-up period, the same patients with poor quality of life were more likely to have abnormal biomarkers of inflammation, more telephone calls and office visits, experience unplanned care, and be exposed to opiates (all P < 0.05). After multivariable analysis, poor quality of life remained an independent predictor of future opiate use (odds ratio: 2.2, P = 0.003) and decreased time to first opiate prescription (hazard ratio: 1.67, P = 0.019) in the follow-up period.

CONCLUSIONS

IBD patients with sustained poor quality of life are at an increased risk of opiate use and decreased time to opiate exposure. Routine measurement of quality of life in the outpatient setting may provide insight into those at risk for narcotic use and healthcare utilization. 10.1093/ibd/izy040_video1izy040.video25791709872001.

摘要

背景

炎症性肠病(IBD)与生活质量差和残疾有关。短炎症性肠病问卷(SIBDQ)经过验证,可用于确定患者在单一时间点的生活质量,或随时间的改善。很少有研究评估持续较差的生活质量是否与未来的医疗保健利用模式相关。

方法

我们分析了前瞻性 IBD 自然史注册研究中具有 4 年连续随访的患者。在门诊就诊时测量 SIBDQ。医疗保健利用数据被暂时组织成 2 年观察期和 2 年随访期。前 2 年的平均 SIBDQ 评分<50 被归类为“生活质量差”。主要研究结果是衡量无计划的医疗保健利用和阿片类药物使用的指标。

结果

在总共 447 名参与者(56.1%为女性,66.1%为克罗恩病,34.9%为溃疡性结肠炎)中,有 215 名(48.1%)被归类为生活质量差。生活质量差与克罗恩病(P < 0.01)、IBD 相关手术史和吸烟史显著相关(均 P < 0.01)。在随访期间,同样生活质量差的患者更有可能出现炎症的生物标志物异常、更多的电话和就诊次数、经历无计划的护理,并接触阿片类药物(均 P < 0.05)。多变量分析后,生活质量差仍然是未来阿片类药物使用的独立预测因素(优势比:2.2,P = 0.003),并且降低了首次阿片类药物处方的时间(风险比:1.67,P = 0.019)在随访期间。

结论

生活质量持续较差的 IBD 患者使用阿片类药物的风险增加,接触阿片类药物的时间减少。在门诊环境中常规测量生活质量可能会洞察到那些有使用麻醉剂和医疗保健利用风险的人。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627a/6124736/e8f85edaef89/izy04001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验